Anti-Microbialvior BioteQ Co (ROCO:6864) ROCE % : -42.41% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Anti-Microbialvior BioteQ Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -42.41%.

Anti-Microbialvior BioteQ Co ROCE % Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co ROCE % Chart

Anti-Microbialvior BioteQ Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-16.27

-15.33

-20.41

-38.52

-41.55

Anti-Microbialvior BioteQ Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial						-25.37	-31.29	-45.63	-43.32	-42.41

Anti-Microbialvior BioteQ Co ROCE % Calculation

Anti-Microbialvior BioteQ Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-74.485	/	( ( (128.047 - 6.994)	+	(248.176 - 10.672) )	/ 2 )
	=	-74.485	/	( (121.053	+	237.504)	/ 2 )
	=	-74.485	/	179.2785
	=	-41.55 %

Anti-Microbialvior BioteQ Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	-86.17	/	( ( (174.602 - 5.748)	+	(248.176 - 10.672) )	/ 2 )
	=	-86.17	/	( ( 168.854	+	237.504 )	/ 2 )
	=	-86.17	/	203.179
	=	-42.41 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

Anti-Microbialvior BioteQ Co (ROCO:6864) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Anti-Microbialvior BioteQ Co ROCE % Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Anti-Microbialvior BioteQ Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741

Website

https://www.ams-bioteq.com

Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines